Clinical treatment of neonatal diarrhoea often uses two drugs, probiotics and montelukast, which regulate intestinal flora, increase beneficial bacteria in the gut and inhibit the invasion of other harmful pathogens and the growth of new bacteria.
Montelukast is actually a protective agent for the intestinal mucosa, the main component is montelukast, which acts as a protective barrier and is mainly used when there is a large amount of watery stool, the drug can inhibit the overproduction of intestinal fluid, reduce fluid loss, adsorb intestinal toxins to a certain extent, and this drug works locally to be excreted through the intestine and is not absorbed into the blood circulation.